236.24
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt WST?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Finanzdaten der West Pharmaceutical Services Inc-Aktie (WST)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
0.05%
805.00
|
804.60 | 766.50 | 698.00 | 748.80 |
| Cost Of Revenue |
1.80%
501.10
|
510.30 | 492.60 | 466.10 | 475.20 |
| Gross Profit |
3.26%
303.90
|
294.30 | 273.90 | 231.90 | 273.60 |
|
|
16.26%
147.30
|
126.70 | 120.20 | 124.90 | 114.00 |
| Benefits Costs and Expenses |
1.71%
643.50
|
632.70 | 609.50 | 587.50 | 583.90 |
| Costs And Expenses |
1.71%
643.50
|
632.70 | 609.50 | 587.50 | 583.90 |
| Operating Income/Loss |
6.56%
156.60
|
167.60 | 153.70 | 107.00 | 159.60 |
| Income/Loss Before Equity Method Investments |
6.05%
161.50
|
171.90 | 157.00 | 110.50 | 164.90 |
| Income/Loss From Equity Method Investments |
85.71%
3.90
|
2.10 | 5.00 | 3.40 | 2.00 |
| Income/Loss From Continuing Operations Before Tax |
6.05%
161.50
|
171.90 | 157.00 | 110.50 | 164.90 |
| Income Tax Expense/Benefit |
2.06%
33.30
|
34.00 | 30.20 | 24.10 | 36.80 |
| Income/Loss From Continuing Operations After Tax |
7.03%
128.20
|
137.90 | 131.80 | 89.80 | 128.10 |
|
|
5.64%
132.10
|
140.00 | 131.80 | 89.80 | 130.10 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
100.00%
-
|
72.20 | 72.20 | 72.50 | -0.10 |
| Diluted Average Shares |
100.00%
-
|
72.60 | 72.50 | 73.00 | -0.10 |
| Basic Earnings Per Share |
5.67%
1.83
|
1.94 | 1.82 | 1.24 | 1.79 |
| Diluted Earnings Per Share |
5.21%
1.82
|
1.92 | 1.82 | 1.23 | 1.78 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):